Fatty liver versus autoimmunity of the bile ducts - defining the gut signals driving steatosis and inflammatory disease of the gut-liver axis

Project Information

FatVersusBile

Grant agreement ID: 101170353

DOI

10.3030/101170353

EC signature date 2 April 2025

Start date 1 May 2025

End date 30 April 2030

Funded under

• European Research Council (ERC)

Total cost

€ 2 000 000,00

EU contribution

€ 2 000 000,00

Coordinated by

UNIVERSITETET I OSLO
Norway

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling

Author(s): Antonio Molinaro, Peder Rustøen Braadland, Guido Carpino, Alba Carreras, Marios Nikolaidis, Petra Hanzely, Katharina R. Beck, Ahmad H. Ali, Lars Bossen, Anna Frank, Annika Lundqvist, Brian D. Juran, Diletta Overi, Lei Geng, Enya Amundsen‑Isaksen, Henrik Mikael Reims, Ida Björk, Krzysztof Grzyb, Andreas Abildgaard, Trine Folseraas, Martin Cornillet, Hólmfríður Helgadóttir, Bryan M. McCauley, Laura Cristoferi, Marco Carbone, Vincenzo Cardinale, Marte L. Høivik, Lise Katrine Engesæter, Sara K. V. Tjønnfjord, Adrian McCann, Per M. Ueland, Mette Vesterhus, Tom H. Karlsen, Henning Grønbæk, Eugenio Gaudio, Konstantinos N. Lazaridis, Annika Bergquist, Espen Melum, Fredrik Bäckhed, Johannes Roksund Hov
Published in: Nature Metabolism, Issue 8, 2026, ISSN 2522-5812
Publisher: Springer Science and Business Media LLC
DOI: 10.1038/S42255-026-01600-1